Kuros Biosciences gained FDA approval for its IND application to initiate a Phase IIA clinical trial evaluating Fibrin-PTH orthobiologic in single-level TLIF to treat degenerative disc disease, with autograft as comparator.
Wellmark Blue Cross Blue Shield established positive coverage for minimally invasive surgical sacroiliac joint fusion using SI-BONE's iFuse Implant System in South Dakota and Iowa.